NCT00661141View on ClinicalTrials.gov

Phase IIa Study of Fomepizole for Acetaldehyde Toxicity After Ethanol Exposure in Subjects With Altered Ethanol Metabolism

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Aldehyde Dehydrogenase-2 (ALDH2) Deficiency
Interventions
DRUG

Antizol

DRUG

Placebo

OTHER

Ethanol

oral dose of ethanol (0.5 g/kg)

Trial Locations (1)

96813

Covance Honolulu CRU, Honolulu

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY